Exploring the Link Between Testosterone and Cardiovascular Health

Written by Adam Maggio | Medically reviewed by Dr. Mitchell Ross, MD, ABAARM

Testosterone influences cardiovascular health by affecting cholesterol, blood pressure, and vascular function, with low or high levels linked to increased heart disease risk.

# The Link Between Testosterone and Cardiovascular Health

Testosterone, the primary male sex hormone, is widely recognized for its role in sexual development, muscle mass, and overall vitality. However, its relationship with cardiovascular health is complex and has been the subject of extensive research. Understanding this link is crucial, especially as men age and testosterone levels naturally decline, potentially influencing heart health.

What Is Testosterone?

Testosterone is an androgen hormone produced mainly by the testes in men and in smaller amounts by the ovaries in women and the adrenal glands in both sexes. It plays a pivotal role in:

  • Sexual function and libido
  • Muscle mass and strength
  • Bone density
  • Mood and cognitive function

    • Normal testosterone levels in men typically range from 300 to 1,000 ng/dL, but levels vary widely depending on age and individual health.

    Testosterone and Cardiovascular Risk: What Does the Evidence Say?

    The relationship between testosterone and cardiovascular disease (CVD) is multifaceted. Both low and high testosterone levels have been implicated in cardiovascular risk, but current evidence generally suggests that low testosterone is often associated with increased cardiovascular risk factors.

    Low Testosterone and Cardiovascular Health

    Several studies have indicated that men with low testosterone levels may have a heightened risk of cardiovascular conditions. Low testosterone is associated with:

  • Increased body fat, particularly visceral adiposity
  • Insulin resistance and type 2 diabetes
  • Dyslipidemia (unhealthy cholesterol profiles)
  • Increased inflammation
  • Endothelial dysfunction (impaired blood vessel function)

    • For example, a meta-analysis published in the American Journal of Cardiology (2019) concluded that low testosterone is linked to a higher incidence of coronary artery disease and cardiovascular mortality.

    Testosterone Replacement Therapy (TRT) and Heart Health

    The use of testosterone replacement therapy, especially in men with clinically low testosterone (hypogonadism), is a common treatment to restore normal levels. However, concerns have been raised regarding TRT and cardiovascular safety.

  • Some observational studies have suggested that TRT may reduce some cardiovascular risks by improving body composition, insulin sensitivity, and lipid profiles.
  • Conversely, other studies and FDA warnings highlight potential increased risks of heart attack, stroke, and death especially in older men with pre-existing heart disease.
  • Recent randomized controlled trials offer more nuanced findings, often reporting no significant increase in cardiovascular events when TRT is appropriately dosed and monitored.

    • Bottom line: The cardiovascular effects of TRT appear to vary depending on patient age, baseline cardiovascular risk, dose, and formulation.

    Mechanisms Linking Testosterone and Cardiovascular Function

    Testosterone may influence cardiovascular health via several biological pathways:

  • Lipid Metabolism: Testosterone can modulate cholesterol levels; normal levels tend to improve HDL (“good” cholesterol) and reduce LDL (“bad” cholesterol).
  • Insulin Sensitivity: Testosterone influences glucose metabolism, potentially reducing insulin resistance.
  • Vascular Effects: Testosterone directly affects blood vessel dilation and endothelial function through nitric oxide release.
  • Inflammation: Testosterone modulates inflammatory cytokines involved in atherosclerosis.
  • Body Composition: Testosterone affects fat distribution and lean muscle mass, which impact cardiovascular risk.

    • Practical Protocol for Testosterone Evaluation and Management

    If cardiovascular health is a concern alongside symptoms suggestive of low testosterone (fatigue, reduced libido, muscle weakness), following a structured evaluation is essential.

    Step 1: Clinical Assessment

  • Document symptoms suggestive of androgen deficiency
  • Assess cardiovascular risk factors (hypertension, diabetes, smoking, lipid profile)
  • Review medication history and existing diseases

    • Step 2: Laboratory Testing

  • Measure total testosterone levels (preferably in the morning)
  • If borderline, consider free testosterone or bioavailable testosterone
  • Evaluate other parameters: lipid panel, glucose, HbA1c, PSA (prostate-specific antigen), hematocrit

    • Step 3: Consider Cardiovascular Evaluation

  • Depending on age and risk factors, perform ECG or stress testing if indicated
  • Optimize management of hypertension, diabetes, and dyslipidemia before any hormone therapy

    • Step 4: Testosterone Replacement Therapy (TRT) — Indications and Dosing

    Only consider TRT in men with confirmed low testosterone and symptomatic hypogonadism after cardiovascular risk assessment and discussion of risks/benefits.

    Common TRT formulations and dosages:

    | Formulation | Typical Starting Dose | Administration Frequency |

    |----------------------|-----------------------------------|--------------------------------|

    | Testosterone enanthate or cypionate (injectable) | 50-100 mg intramuscularly | Every 1-2 weeks |

    | Testosterone gel (topical) | 50-100 mg applied daily | Daily |

    | Testosterone patches | 4-6 mg applied daily | Daily |

    Dosage must be individualized and monitored with repeat testosterone levels and clinical symptoms every 3-6 months.

    Monitoring During TRT

  • Testosterone levels to maintain within mid-normal range
  • Hematocrit to avoid polycythemia (check every 3-6 months)
  • PSA and prostate exams (especially in men >40 years)
  • Cardiovascular status and lipid profile

    • Important Considerations and Warnings

  • TRT is not recommended for men with active prostate or breast cancer.
  • Individuals with severe cardiovascular disease need careful risk-benefit discussion.
  • Lifestyle interventions (weight loss, exercise, smoking cessation) remain foundational for cardiovascular health.
  • Always consult a healthcare provider before starting or modifying hormone therapy.

    • Conclusion

    The link between testosterone and cardiovascular health is complex and still being elucidated. Low testosterone levels are often associated with increased cardiovascular risk factors, whereas testosterone replacement therapy may improve some metabolic profiles but requires cautious use, especially in men with existing heart disease.

    Men experiencing symptoms suggestive of low testosterone should seek medical evaluation that includes both hormonal and cardiovascular assessment. When indicated, carefully monitored testosterone therapy can be part of a comprehensive strategy to improve quality of life and metabolic health, but it must be personalized to each patient's risk profile.

    Always consult with a healthcare provider to evaluate the benefits and risks of testosterone therapy in relation to cardiovascular health.

    ---

    References

  • Shores MM, Matsumoto AM. Testosterone and cardiovascular disease. J Clin Endocrinol Metab. 2014;99(3):1020-1033.
  • Corona G, et al. Testosterone and cardiovascular risk: meta-analysis of observational studies. Eur Heart J. 2018;39(12):1080-1093.
  • Basaria S, et al. Adverse events associated with testosterone administration. N Engl J Med. 2010;363(2):109-122.
  • American College of Cardiology. Testosterone Therapy and Cardiovascular Risk: ACC Expert Consensus. 2019.